Mitotic Inhibitors: Taxanes and Vinca Alkaloids
Taxanes and vinca alkaloids disrupt microtubule dynamics through opposing mechanisms, both causing mitotic arrest and apoptosis in cancer cells.
Overview
Mitotic inhibitors target the mitotic spindle, a structure composed of microtubule polymers that segregate chromosomes during cell division. Disruption of microtubule dynamics triggers the spindle assembly checkpoint, causing mitotic arrest and apoptotic cell death. These drugs are M-phase specific and are among the most effective anticancer agents.
Microtubule Biology
Microtubules are dynamic polymers of alpha/beta-tubulin dimers that undergo rapid assembly (polymerization) and disassembly (depolymerization) — a process called dynamic instability. This treadmilling behavior is essential for spindle formation and chromosome segregation. Drugs that either stabilize or destabilize microtubules abolish dynamic instability, preventing proper spindle function.
Taxanes (Microtubule Stabilizers)
Taxanes bind to the beta-tubulin subunit on polymerized microtubules, stabilizing them and preventing depolymerization. This freezes the spindle, activates the spindle assembly checkpoint, and induces apoptosis.
Paclitaxel (Taxol) is derived from the Pacific yew tree. It is formulated in Cremophor EL (causing hypersensitivity reactions; premedicate with dexamethasone, diphenhydramine, and H2 antagonists) or as nab-paclitaxel (albumin-bound, avoids Cremophor). Used in breast, ovarian, NSCLC, and gastric cancers.
Docetaxel has greater binding affinity for tubulin than paclitaxel and is active in breast, prostate (CRPC), NSCLC, and gastric cancers. Causes fluid retention (manage with dexamethasone premedication).
Cabazitaxel is a semi-synthetic taxane that overcomes P-glycoprotein-mediated resistance to docetaxel; used in CRPC after docetaxel failure.
Vinca Alkaloids (Microtubule Destabilizers)
Vinca alkaloids (from Catharanthus roseus) bind to beta-tubulin at the vinca domain, preventing polymerization and causing microtubule depolymerization. Spindle formation fails, and mitotic arrest triggers apoptosis.
Vincristine is used in lymphomas, leukemias (ALL induction), and pediatric solid tumors. Its dose-limiting toxicity is peripheral neuropathy (not myelosuppression), allowing it to be combined with myelosuppressive agents without additive marrow toxicity.
Vinblastine causes more myelosuppression and less neuropathy than vincristine. Used in Hodgkin lymphoma (ABVD) and testicular cancer (BEP).
Vinorelbine is used in NSCLC and breast cancer; available orally and IV.
Key Takeaways
- Taxanes stabilize microtubules (prevent depolymerization); vinca alkaloids destabilize them (prevent polymerization)
- Both classes cause mitotic arrest via spindle assembly checkpoint activation
- Vincristine is dose-limited by neuropathy, not myelosuppression — important for combination design
- Nab-paclitaxel avoids Cremophor-related hypersensitivity; cabazitaxel overcomes taxane resistance